Abstract
Cancer cachexia is associated with muscle weakness and atrophy. We investigated whether 1α,25-dihydroxyvitamin D3 (1α,25(OH)2D3), which has previously been shown to increase skeletal myoblast oxygen consumption rate, could reverse the deleterious effects of tumor cell conditioned medium on myoblast function. Conditioned medium from Lewis lung carcinoma (LLC1) cells inhibits oxygen consumption, increases mitochondrial fragmentation, inhibits pyruvate dehydrogenase activity, and enhances proteasomal activity in human skeletal muscle myoblasts. 1α,25(OH)2D3 reverses the tumor cell-mediated changes in mitochondrial oxygen consumption and proteasomal activity, without changing pyruvate dehydrogenase activity. 1α,25(OH)2D3 might be useful in treatment of weakness seen in association with CC.
Original language | English (US) |
---|---|
Pages (from-to) | 746-752 |
Number of pages | 7 |
Journal | Biochemical and Biophysical Research Communications |
Volume | 496 |
Issue number | 2 |
DOIs | |
State | Published - Feb 5 2018 |
Keywords
- 1α,25-dihydroxyvitamin D
- Cancer
- Gene expression
- Mitochondria
- Oxygen consumption
- Skeletal muscle
ASJC Scopus subject areas
- Biophysics
- Biochemistry
- Molecular Biology
- Cell Biology